PROTECT Prevent and Bypass - a Vision to Protect Blood Cells from Adverse Immune Responses
- Coordinator
- Universitatsmedizin Greifswald Korperschaft Des Offentlichen Rechts, Germany
- Runs
- 1 October 2026 to 30 September 2031
- Status
- Running
- EU funding
- €2.5m
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101264330
What the project is doing
In the project's own words, from its summary on CORDIS.
PROTECT: Advancing Blood Cell Protection from Immune Attack This ERC Advanced Grant project, PROTECT, aims to overcome challenges in preventing adverse immune responses against blood cells induced by essential medical interventions: vaccination, transfusion, and thrombosis prophylaxis. Despite their life-saving potential, these therapies can trigger rare but severe complications due to antibody-mediated immune activation.
PROTECT addresses this through two interconnected challenges: PREVENT, focusing on adenovirus vector vaccine safety by elucidating the mechanisms behind vaccine-induced immune thrombocytopenia and thrombosis (VITT); and BYPASS, aiming to enable safe transfusions for immunized patients by enzymatically removing antigenic proteins from donor blood cells. PREVENT will investigate the specific adenoviral components triggering the anti-PF4 response, utilizing advanced proteomics, genetics, and humanized mouse models.
BYPASS will leverage innovative enzyme engineering and targeted protein degradation to modify blood products in situ, offering a paradigm shift in transfusion medicine. By integrating mechanistic insights with translational approaches, PROTECT strives to develop preventative and corrective strategies, ultimately preserving public trust in life-saving medical practices and establishing a unique human model system for alloimmunization research.
This ambitious program promises high-gain potential with lasting impact on patient care and blood product safety.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitatsmedizin Greifswald Korperschaft Des Offentlichen Rechts | Greifswald | Germany | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI